| Question 1: A quick and efficient roll-out of RO-ILS is facilitated by each of the following except: |
| Reference: | RO-ILS Participation Guide, 2019: https://www.astro.org/Patient-Care-and-Research/Patient-Safety/RO-ILS/Participation |
| Choice A: | Support from upper management |
| Choice B: | Administrative restriction on sign-up |
| Choice C: | A physics staff member/team to coordinate the process |
| Choice D: | Positive training of staff members |
| Question 2: Which of the following is a unique challenge in incident learning faced by a proton center? |
| Reference: | PTCOG Report #2, PTCOG Safety Group Report on Aspects of Safety in Particle Therapy Version 2, 2016. Flanz, J. et al. |
| Choice A: | Proton therapy inherently has more errors than photon therapy |
| Choice B: | Proton centers don’t like to share information with other centers |
| Choice C: | There are fewer peer centers to learn from and benchmark against, compared to photon therapy |
| Choice D: | Proton therapy staff has less time for incident learning than photon therapy staff |
| Question 3: Corrective/preventive actions to medical events require the following information except: |
| Reference: | Ford E, Suzanne BE Incident learning in radiation oncology: a review, Med Phys, 45(5), e100-120, 2018 |
| Choice A: | Details on when the event occurred |
| Choice B: | Details on how it happened |
| Choice C: | What exactly happened |
| Choice D: | Institution name and location |
| Question 4: All of the following are valuable items in the playbook except: |
| Reference: | Ford E, Suzanne BE Incident learning in radiation oncology: a review, Med Phys, 45(5), e100-120, 2018 |
| Choice A: | Collect different feedback from different people |
| Choice B: | Encourage manufacturer participation |
| Choice C: | Create and environment of interaction and information sharing |
| Choice D: | Identify irresponsible clinical staff |
| Choice E: | Identify weaknesses in the processes |
| Question 5: Which of the following safety efforts made by AAPM and/or ASTRO are directly supported by data reported to the RO-ILS database and presented in the quarterly reports? |
| Reference: | Ezzell G, Chera B, Dicker A, Ford E, Potters L, Santanam L, Weintraub S. Common error pathways seen in the RO-ILS data that demonstrate opportunities for improving treatment safety. Pract Radiat Oncol. 2018 Mar - Apr;8(2):123-132. doi: 10.1016/j.prro.2017.10.007. Epub 2018 Jan 9. |
| Choice A: | Standardizing dose prescriptions: An ASTRO white paper |
| Choice B: | Standardizing Normal Tissue Contouring for Radiation Therapy Treatment Planning: An ASTRO Consensus Paper |
| Choice C: | American Association of Physicists in Medicine Task Group 263: Standardizing Nomenclatures in Radiation Oncology |
| Choice D: | The report of Task Group 100 of the AAPM: Application of risk analysis methods to radiation therapy quality management |
| Choice E: | A and B only |
| Choice F: | C and D only |
| Question 6: Which of the following three common, high-severity error pathways identified by Ezzell et al seems to support a need for more robust physician peer review? |
| Reference: | Ezzell G, Chera B, Dicker A, Ford E, Potters L, Santanam L, Weintraub S. Common error pathways seen in the RO-ILS data that demonstrate opportunities for improving treatment safety. Pract Radiat Oncol. 2018 Mar - Apr;8(2):123-132. doi: 10.1016/j.prro.2017.10.007. Epub 2018 Jan 9. |
| Choice A: | Problematic plan approved for treatment |
| Choice B: | Wrong shift instructions given to therapists |
| Choice C: | Wrong shift performed at treatment |
| Choice D: | All of these support more robust physician peer review |
